Helping You Build Wealth With Honest Research
Since 1996. Read On…
Claim Your Access Now
**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.
Image source: smagilov/www.istockphoto.comIndian benchmark indices traded positive throughout the session and ultimately closed green.
Indian equity benchmarks indices, Sensex and Nifty50 closed sharply lower on Friday, weighed down by uncertainty over the US-Iran deal, with selling pressure broad-based across sectors.
At the closing bell, the BSE Sensex closed 1,092 points lower (down 1.4%)
Meanwhile, the NSE Nifty closed 359 points lower (down 1.5%)
You can also visit our live blog section for real-time updates and deeper insights into the market.
Tech Mahindra, HCL Tech, Asian Paints were the top gainers today.
Bajaj Finance, Tata Steel, UltraTech Cement on the other hand, were among the top losers today.
The BSE 150 Midcap index is trading 1.2% lower and the BSE 250 SmallCap index is trading 0.6% lower.
Baring IT sector and telecommunication sector all other sectoral indices were trading negative today with metal and oil & gas sector witnesses selling pressure.
For impact of the Bank Nifty companies and comprehensive overview of the index, check out Equitymaster’s Bank Nifty Companies list.
Speaking of stock markets, Richa Agarwal Research Analyst at Equitymaster highlights that AI has emerged as a major risk for legacy IT companies.
This concern is reflected in the sharp correction in the BSE IT, which has declined over 20%.
However, the sell-off may eventually become overdone, creating potential value opportunities in select IT stocks. Watch the video below to know more.
Physicswallah share price will be in focus today.
Shares of Physicswallah came into focus after the company reported its Q4 FY26 results.
In the March quarter, PhysicsWallah reduced its consolidated net loss to Rs 0.75 bn from Rs 2.93 bn a year earlier.
Ashok Leyland share price will be in focus today.
Shares of Ashok Leyland came into focus after the company reported its Q4 FY26 results.
Ashok Leyland reported Q4FY26 revenue growth of 18.9% year-on-year and 22.8% quarter-on-quarter to Rs 141.61 bn, driven by 17.4% YoY growth in volumes and a 1.3% rise in average selling price (ASP).
Shares of Wipro came into focus after the company announced an expanded partnership with ServiceNow to implement and scale agentic artificial intelligence (AI) workflows across core enterprise functions, including information technology (IT), human resources, procurement, and cybersecurity.
Under the partnership, Wipro will integrate its AI platform, Wipro Intelligence, with the ServiceNow AI Platform to help businesses automate and manage work more efficiently across different systems.
The move is expected to reduce manual effort, improve workflow visibility, speed up task completion, and strengthen operational control.
As part of the collaboration, Wipro’s SmartProcure solution will simplify procurement processes, Telco Autonomous Networks will help telecom companies improve service operations and resolve issues faster, and Cyber Transform will enhance cybersecurity by streamlining vulnerability management and incident response.
Shares of Alkem Laboratories came into focus after the company reported its Q4 FY26 results.
In the March quarter, Alkem Laboratories reported a 22.7% year-on-year (Y-o-Y) decline in consolidated net profit to Rs 2.36 billion.
However, revenue from operations increased 14.6% to Rs 36.03 billion. Profit was affected by one-time exceptional items and a higher tax charge.
Tata Elxsi has launched AnaTel, an AI-native software development platform for healthcare and medical technology companies, developed in partnership with OpenAna. The platform was unveiled at DeviceTalks Boston 2026.
AnaTel is designed to help healthcare and medtech companies simplify software development while meeting increasingly strict regulatory requirements. Instead of manually creating documents, test records, and compliance reports across multiple tools, the platform uses AI agents to automate these tasks throughout the software development process.
The platform can generate code, documentation, test cases, and regulatory records while supporting compliance requirements such as traceability, validation evidence, and audit documentation. Human engineers and regulatory experts continue to oversee key decisions and reviews.
According to Tata Elxsi, AnaTel can reduce Software as a Medical Device (SaMD) development and change assessment timelines from around eight weeks to just 72 hours, while improving productivity by up to 60%. The platform combines Tata Elxsi’s experience in regulated medical device software with OpenAna’s AI engineering technology.
To know what’s moving the Indian stock markets today, check out the most recent share market updates here
View all commentaries | Archives
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on “Wipro Expands ServiceNow Partnership for AI | Tata Elxsi Launches AI-Native Software Platform | Top Buzzing Stocks Today“. Click here!
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here’s why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
Copyright © Quantum Information Services Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Quantum Information Services Private Limited
103, Regent Chambers, Nariman Point, Mumbai 400021
U65990MH1989PTC054667
www.equitymaster.com
Ms. Sonal Ramachandran
SEBI Registration No.: INH000021128 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 6769
Principal Officer: Tanushree Banerjee | Telephone No.:+91-22-61434055 | Email: po.ra@equitymaster.com
SEBI Registration No.: INA000000680 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 1488
Principal Officer: Vivek Chaurasia | Telephone No.:+91-22-61434055 | Email: po.ria@equitymaster.com
SEBI Bhavan BKC
Address: Plot No.C4-A, ‘G’ Block Bandra-Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra
Telephone No.: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22 | Email: sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575
SCORES: https://www.scores.gov.in/ | SMARTODR: https://smartodr.in/login
AMFI Registered Mutual Fund Distributor
AMFI Registration Number : ARN – 1022
Date of Initial Registration : 28 / JAN / 2008
Current Validity of ARN upto : 28 / JAN / 2028
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.
Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand ‘Equitymaster’ and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an ‘As Is’ basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user’s own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.
The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS’s content and website, you agree to our Terms and Conditions of Use, available here.
Leave a Reply